Robert Falcon

Robert Falcon currently serves as the Executive Director of Global Commercial Training, Development, and Field Execution at Ultragenyx, having held progressively responsible roles within the company since September 2021. With a robust background in commercial training and product launch strategies, Robert has demonstrated expertise in leading sales training initiatives for specialized therapeutic areas, including metabolic bone diseases and liver diseases. Previous roles include significant positions at Intercept Pharmaceuticals, Aegerion Pharmaceuticals, and Merck, where Robert contributed to the development of training infrastructures, sales strategies, and marketing support services, achieving measurable outcomes in revenue and customer experience. Robert holds a Bachelor of Science degree in Human Kinetics from Rutgers University.